Reviews Dexilant


No reviews yet.

Dexilant Drug Description
Dexilant (formerly Kapidex)
(dexlansoprazole) Delayed Release Capsules
DRUG DESCRIPTION
The active ingredient in DEXILANT (dexlansoprazole) delayed release capsules
is (+)-2-[(R)-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylj methyl} sulfinyl]-7H-benzimidazole,
a compound that inhibits gastric acid secretion. Dexlansoprazole is the R-enantiomer
of lansoprazole (a racemic mixture of the R- and S-enantiomers). Its empirical
formula is: C16H14F3N3O2S, with a molecular weight of 369.36. The structural
formula is:







Dexlansoprazole is a white to nearly white crystalline powder which melts with decomposition at 140°C. Dexlansoprazole is freely soluble in dimethylformamide, methanol, dichloromethane, ethanol, and ethyl acetate; and soluble in acetonitrile; slightly soluble in ether; and very slightly soluble in water; and practically insoluble in hexane.
Dexlansoprazole is stable when exposed to light. Dexlansoprazole is more stable in neutral and alkaline conditions than acidic conditions.
DEXILANT is supplied as a dual delayed release formulation in capsules for
oral administration. The capsules contain dexlansoprazole in a mixture of two
types of enteric-coated granules with different pH-dependent dissolution profiles
[see CLINICAL PHARMACOLOGY].
DEXILANT is available in two dosage strengths: 30 mg and 60 mg, per capsule. Each capsule contains enteric-coated granules consisting of dexlansoprazole (active ingredient) and the following inactive ingredients: sugar spheres, magnesium carbonate, sucrose, low-substituted hydroxypropyl cellulose, titanium dioxide, hydroxypropyl cellulose, hypromellose 2910, talc, methacrylic acid copolymers, polyethylene glycol 8000, triethyl citrate, polysorbate 80, and colloidal silicon dioxide. The components of the capsule shell include the following inactive ingredients: hypromellose, carrageenan and potassium chloride. Based on the capsule shell color, blue contains FD&C Blue No. 2 and aluminum lake; gray contains ferric oxide and aluminum lake; and both contain titanium dioxide.Last reviewed on RxList: 7/29/2010




Dexilant Drug Description
Dexilant (formerly Kapidex)
(dexlansoprazole) Delayed Release Capsules
DRUG DESCRIPTION
The active ingredient in DEXILANT (dexlansoprazole) delayed release capsules
is (+)-2-[(R)-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylj methyl} sulfinyl]-7H-benzimidazole,
a compound that inhibits gastric acid secretion. Dexlansoprazole is the R-enantiomer
of lansoprazole (a racemic mixture of the R- and S-enantiomers). Its empirical
formula is: C16H14F3N3O2S, with a molecular weight of 369.36. The structural
formula is:







Dexlansoprazole is a white to nearly white crystalline powder which melts with decomposition at 140°C. Dexlansoprazole is freely soluble in dimethylformamide, methanol, dichloromethane, ethanol, and ethyl acetate; and soluble in acetonitrile; slightly soluble in ether; and very slightly soluble in water; and practically insoluble in hexane.
Dexlansoprazole is stable when exposed to light. Dexlansoprazole is more stable in neutral and alkaline conditions than acidic conditions.
DEXILANT is supplied as a dual delayed release formulation in capsules for
oral administration. The capsules contain dexlansoprazole in a mixture of two
types of enteric-coated granules with different pH-dependent dissolution profiles
[see CLINICAL PHARMACOLOGY].
DEXILANT is available in two dosage strengths: 30 mg and 60 mg, per capsule. Each capsule contains enteric-coated granules consisting of dexlansoprazole (active ingredient) and the following inactive ingredients: sugar spheres, magnesium carbonate, sucrose, low-substituted hydroxypropyl cellulose, titanium dioxide, hydroxypropyl cellulose, hypromellose 2910, talc, methacrylic acid copolymers, polyethylene glycol 8000, triethyl citrate, polysorbate 80, and colloidal silicon dioxide. The components of the capsule shell include the following inactive ingredients: hypromellose, carrageenan and potassium chloride. Based on the capsule shell color, blue contains FD&C Blue No. 2 and aluminum lake; gray contains ferric oxide and aluminum lake; and both contain titanium dioxide.Last reviewed on RxList: 7/29/2010




Dexilant Drug Description
Dexilant (formerly Kapidex)
(dexlansoprazole) Delayed Release Capsules
DRUG DESCRIPTION
The active ingredient in DEXILANT (dexlansoprazole) delayed release capsules
is (+)-2-[(R)-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylj methyl} sulfinyl]-7H-benzimidazole,
a compound that inhibits gastric acid secretion. Dexlansoprazole is the R-enantiomer
of lansoprazole (a racemic mixture of the R- and S-enantiomers). Its empirical
formula is: C16H14F3N3O2S, with a molecular weight of 369.36. The structural
formula is:







Dexlansoprazole is a white to nearly white crystalline powder which melts with decomposition at 140°C. Dexlansoprazole is freely soluble in dimethylformamide, methanol, dichloromethane, ethanol, and ethyl acetate; and soluble in acetonitrile; slightly soluble in ether; and very slightly soluble in water; and practically insoluble in hexane.
Dexlansoprazole is stable when exposed to light. Dexlansoprazole is more stable in neutral and alkaline conditions than acidic conditions.
DEXILANT is supplied as a dual delayed release formulation in capsules for
oral administration. The capsules contain dexlansoprazole in a mixture of two
types of enteric-coated granules with different pH-dependent dissolution profiles
[see CLINICAL PHARMACOLOGY].
DEXILANT is available in two dosage strengths: 30 mg and 60 mg, per capsule. Each capsule contains enteric-coated granules consisting of dexlansoprazole (active ingredient) and the following inactive ingredients: sugar spheres, magnesium carbonate, sucrose, low-substituted hydroxypropyl cellulose, titanium dioxide, hydroxypropyl cellulose, hypromellose 2910, talc, methacrylic acid copolymers, polyethylene glycol 8000, triethyl citrate, polysorbate 80, and colloidal silicon dioxide. The components of the capsule shell include the following inactive ingredients: hypromellose, carrageenan and potassium chloride. Based on the capsule shell color, blue contains FD&C Blue No. 2 and aluminum lake; gray contains ferric oxide and aluminum lake; and both contain titanium dioxide.Last reviewed on RxList: 7/29/2010




Dexilant Drug Description
Dexilant (formerly Kapidex)
(dexlansoprazole) Delayed Release Capsules
DRUG DESCRIPTION
The active ingredient in DEXILANT (dexlansoprazole) delayed release capsules
is (+)-2-[(R)-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylj methyl} sulfinyl]-7H-benzimidazole,
a compound that inhibits gastric acid secretion. Dexlansoprazole is the R-enantiomer
of lansoprazole (a racemic mixture of the R- and S-enantiomers). Its empirical
formula is: C16H14F3N3O2S, with a molecular weight of 369.36. The structural
formula is:







Dexlansoprazole is a white to nearly white crystalline powder which melts with decomposition at 140°C. Dexlansoprazole is freely soluble in dimethylformamide, methanol, dichloromethane, ethanol, and ethyl acetate; and soluble in acetonitrile; slightly soluble in ether; and very slightly soluble in water; and practically insoluble in hexane.
Dexlansoprazole is stable when exposed to light. Dexlansoprazole is more stable in neutral and alkaline conditions than acidic conditions.
DEXILANT is supplied as a dual delayed release formulation in capsules for
oral administration. The capsules contain dexlansoprazole in a mixture of two
types of enteric-coated granules with different pH-dependent dissolution profiles
[see CLINICAL PHARMACOLOGY].
DEXILANT is available in two dosage strengths: 30 mg and 60 mg, per capsule. Each capsule contains enteric-coated granules consisting of dexlansoprazole (active ingredient) and the following inactive ingredients: sugar spheres, magnesium carbonate, sucrose, low-substituted hydroxypropyl cellulose, titanium dioxide, hydroxypropyl cellulose, hypromellose 2910, talc, methacrylic acid copolymers, polyethylene glycol 8000, triethyl citrate, polysorbate 80, and colloidal silicon dioxide. The components of the capsule shell include the following inactive ingredients: hypromellose, carrageenan and potassium chloride. Based on the capsule shell color, blue contains FD&C Blue No. 2 and aluminum lake; gray contains ferric oxide and aluminum lake; and both contain titanium dioxide.Last reviewed on RxList: 7/29/2010




Dexilant Drug Description
Dexilant (formerly Kapidex)
(dexlansoprazole) Delayed Release Capsules
DRUG DESCRIPTION
The active ingredient in DEXILANT (dexlansoprazole) delayed release capsules
is (+)-2-[(R)-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylj methyl} sulfinyl]-7H-benzimidazole,
a compound that inhibits gastric acid secretion. Dexlansoprazole is the R-enantiomer
of lansoprazole (a racemic mixture of the R- and S-enantiomers). Its empirical
formula is: C16H14F3N3O2S, with a molecular weight of 369.36. The structural
formula is:







Dexlansoprazole is a white to nearly white crystalline powder which melts with decomposition at 140°C. Dexlansoprazole is freely soluble in dimethylformamide, methanol, dichloromethane, ethanol, and ethyl acetate; and soluble in acetonitrile; slightly soluble in ether; and very slightly soluble in water; and practically insoluble in hexane.
Dexlansoprazole is stable when exposed to light. Dexlansoprazole is more stable in neutral and alkaline conditions than acidic conditions.
DEXILANT is supplied as a dual delayed release formulation in capsules for
oral administration. The capsules contain dexlansoprazole in a mixture of two
types of enteric-coated granules with different pH-dependent dissolution profiles
[see CLINICAL PHARMACOLOGY].
DEXILANT is available in two dosage strengths: 30 mg and 60 mg, per capsule. Each capsule contains enteric-coated granules consisting of dexlansoprazole (active ingredient) and the following inactive ingredients: sugar spheres, magnesium carbonate, sucrose, low-substituted hydroxypropyl cellulose, titanium dioxide, hydroxypropyl cellulose, hypromellose 2910, talc, methacrylic acid copolymers, polyethylene glycol 8000, triethyl citrate, polysorbate 80, and colloidal silicon dioxide. The components of the capsule shell include the following inactive ingredients: hypromellose, carrageenan and potassium chloride. Based on the capsule shell color, blue contains FD&C Blue No. 2 and aluminum lake; gray contains ferric oxide and aluminum lake; and both contain titanium dioxide.Last reviewed on RxList: 7/29/2010





Other reviews about Dexilant on wordpress

Kapidex / Dexilant (dexlansoprazole): another stupid drug that should not exist.
  by ludditeandroid
UPDATE: To avoid being confused with Casodex, Kapidex has changed its name to Dexilant. Every pharmaceutical trade magazine I've been reading recently has an ad for Kapidex (dexlansoprazole) in […]


Heartburn Drug Kapidex Renamed to Dexilant
  by timeinctemp
THURSDAY, March 4 (HealthDay News) — Kapidex (dexlansoprazole) has been given the new name Dexilant -- so approved by the U.S. Food and Drug Administration — to avoid […]


FDA Approves Name Change for Heartburn Drug Kapidex
  by ssgt leslie
FDA NEWS RELEASE For Immediate Release: March 4, 2010 Media Inquiries: Elaine Gansz Bobo, 301-796-7567; elaine.bobo@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA Change to Dexilant is part of FDA effort to prevent medication errors The U.S. […]


Name Change for Kapidex (Dexlansoprazole)
  by Marvin Pankaskie
The U.S. Food and Drug Administration has approved a name change for the heartburn drug Kapidex (dexlansoprazole) to avoid confusion with two other medications – Casodex and Kadian. […]


Impactiviti Daily 042710 Top Pharma News
  by Steve Woodruff
***** TODAY’S NEWS The name is changed, but the pump remains the same - Kapidex (proton pump inhibitor from Takeda) is now Dexilant. Covidien launches Exalgo (pain reliefe) and […]


FDA Warns of Fracture Risk With Popular Heartburn Drugs
  by nalonsospc
By Steven ReinbergHealthDay Reporter TUESDAY, May 25 (HealthDay News) -- Blockbuster heartburn medications such as Prevacid, Prilosec and Nexium will now carry a warning on their labels linking the […]


Increased Risk of Fractures with Proton Pump Inhibitors
  by Marvin Pankaskie
he U.S. Food and Drug Administration (FDA) is revising the prescription and over-the-counter (OTC) labels for a class of drugs called proton pump inhibitors to include […]


FDA Warns of Fracture Risk With Popular Heartburn Drugs
  by kether1985
FDA Warns of Fracture Risk With Popular Heartburn Drugs By Steven Reinberg HealthDay Reporter by […]


Possible increased risk of fractures with use of PPIs, says FDA
  by zedie
Possible increased risk of fractures with use of PPIs, says FDA […]


FDA Warns of Fracture Risk From Acid Reflux Drugs
  by zedie
PPI Antacids Linked to Hip, Wrist, and Spine Fracture May 25, 2010 -- Popular PPI antacids -- Aciphex, Dexilant, Nexium, Prevacid, Prilosec, Protonix, Vimovo, and Zegerid […]



Other reviews about Dexilant on web:

Find DEXILANT (dexlansoprazole) medication information. Learn about DEXILANT, including side effects, dosage, how it works, and more. Important Safety Information: DEXILANT may ... Welcome to the Official Site of DEXILANT™ (dexlansoprazole)


Dexilant is a proton pump inhibitor that is prescribed to treat GERD and erosive esophagitis. Lean about special precautions and side effects for this medication. Acid Reflux Treatment - Dexilant for Acid Reflux Treatment


Accurate, FDA approved Dexilant information for healthcare professionals and patients - brought to you by Drugs.com. Dexilant Official FDA information, side effects and uses.


Heartburn and acid reflux questions and answers. Learn about gastroesophageal reflux disease, including symptoms, causes, and treatments, and get tips to help manage heartburn. DEXILANT™ (dexlansoprazole) Official Site: DEXILANT FAQs


Learn about the prescription medication Dexilant (Dexlansoprazole Delayed Release Capsules), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient ... Dexilant (Dexlansoprazole Delayed Release Capsules) Drug ...


Dexilant is a prescription medicine used to decrease stomach acid. This eMedTV Web page offers an in-depth look at the medicine, including information on what it is used to ... Dexilant


Dexilant (dexlansoprazole) patient information. Detailed drug information for the consumer, includes dosage, Dexilant side effects and more. Dexilant consumer information from Drugs.com


Deerfield, Ill., (March 4, 2010) – Takeda Pharmaceuticals North America, Inc. announced today that KAPIDEX ™ (dexlansoprazole) will be marketed in the United States ... KAPIDEX™ (dexlansoprazole) Renamed DEXILANT™ in U.S. to Avoid ...


Dexilant is a medication used to treat acid reflux (also called GERD). Dexilant is different than most medications of its kind because, like an extended release type medication ... Dexilant - What is Dexilant


DEXILANT (Dexlansoprazole) drug information for Erosive esophagitis, GERD {GERD} from MPR including side effects, drug interactions, dosing, contraindications and warnings ... DEXILANT (Dexlansoprazole) drug information from MPR





Featured Reviews

Reviews Vaseretic

Vaseretic Drug Description VASERETIC® (enalapril maleate-hydrochlorothiazide) Tablets USE IN PREGNANCY When used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing...
Read More  |  Review This
Reviews Apomorphine

Apokyn Drug Description APOKYN® (apomorphine hydrochloride) Injection 10 mg/mL For Subcutaneous Use Only Not for IV Use DRUG DESCRIPTION What are the possible side effects of apomorphine (Apokyn)? Get emergency medical help...
Read More  |  Review This
Reviews Prochlorperazine Maleate Tablets

Prochlorperazine Maleate Tablets Drug Description PROCHLORPERAZINE MALEATE TABLETS USP DRUG DESCRIPTION Prochlorperazine Maleate is classified as an antiemetic and antipsychotic tranquilizer. Prochlorperazine is a phenothiazine derivative,...
Read More  |  Review This
Reviews Morphine Sulfate XR Liposome Injection

DepoDur Drug Description DepoDur® (morphine sulfate) Extended-Release Liposome Injection DRUG DESCRIPTION DepoDur (morphine sulfate) extended-release liposome injection is a sterile suspension of multivesicular liposomes using proprietary...
Read More  |  Review This
Reviews Cafcit

Cafcit Drug Description CAFCIT® (caffeine citrate) Injection CAFCIT® (caffeine citrate) Oral Solution DRUG DESCRIPTION What are the possible side effects of caffeine citrate (Cafcit)? Get emergency medical help if...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....